Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young Adult Prader-Willi Growth Hormone Study
2011-001313-14Phase 3Active
- Sponsor
- Dutch Growth Research Foundation
- Start
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in Prader-Willi syndrome (PWS) and growth hormone deficiency (GHD), sponsored by Dutch Growth Research Foundation. Primary endpoints: Weight and Waist-hip ratio. Started Jan 2012; status: active.
02
Drugs
somatropin
03
Conditions
Prader-Willi syndrome (PWS)growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2011-001313-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001313-14.